Healthcare & Life Sciences

Syndesi Therapeutics

Belgium
Sign in to unlock

About

Syndesi Therapeutics develops novel modulators of the synaptic vesicle protein SV2A based on research conducted at UCB, aiming to advance biopharmaceutical therapies for central nervous system disorders.

Explore Syndesi Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing